Trial Profile
A Phase II Trial of Erlotinib in Combination With Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Erlotinib (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 31 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Jun 2009 New trial record